7Baggers
 BioXcel Investors Advance Suit Over FDA Study Compliance Issues  Bloomberg Law News Tue, 30 Sep 2025 19:51:00 GMT
 User  FinancialContent Sat, 27 Sep 2025 18:55:52 GMT
 BioXcel Therapeutics stock rating reiterated at Buy by H.C. Wainwright  Investing.com Mon, 22 Sep 2025 07:00:00 GMT
 BioXcel Therapeutics regains Nasdaq compliance after MVLS issue  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 BioXcel Therapeutics (BTAI) Regains Nasdaq Compliance  GuruFocus Thu, 18 Sep 2025 07:00:00 GMT
 bioxcel therapeutics completes enrollment in clinical study  TipRanks Mon, 15 Sep 2025 14:19:47 GMT
 btai completes enrollment in key clinical study  GuruFocus Mon, 15 Sep 2025 13:38:39 GMT
 bioxcel therapeutics, inc. provides clinical trial update  MarketScreener Mon, 15 Sep 2025 12:31:00 GMT
 Bioxcel Therapeutics Files Current Report on Form 8-K  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 transcript : bioxcel therapeutics, inc. - special call  MarketScreener Wed, 10 Sep 2025 19:50:21 GMT
 bioxcel reports positive efficacy data for at-home agitation treatment  Investing.com Wed, 10 Sep 2025 11:10:00 GMT
 BioXcel Therapeutics Reports Positive Phase 3 Trial Results  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 bioxcel therapeutics : serenity at home topline september 10  MarketScreener Wed, 10 Sep 2025 07:00:00 GMT
 BioXcel Therapeutics at H.C. Wainwright: Expanding IGALMI’s Reach  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 bioxcel therapeutics, inc. (nasdaq:btai) short interest update  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 bioxcel therapeutics receives positive fda feedback  MSN Sat, 06 Sep 2025 20:40:03 GMT
 canaccord genuity reaffirms their buy rating on bioxcel therapeutics (btai)  The Globe and Mail Sat, 06 Sep 2025 11:10:00 GMT
 published on: 2025-09-04 06:34:10  Newser Thu, 04 Sep 2025 11:34:10 GMT
 published on: 2025-09-04 05:32:53  Newser Thu, 04 Sep 2025 10:32:53 GMT
 bioxcel therapeutics receives positive fda feedback  MSN Fri, 29 Aug 2025 19:00:04 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Fri, 29 Aug 2025 10:38:00 GMT
 BioXCel seeks Igalmi label expansion after Phase III success  Clinical Trials Arena Fri, 29 Aug 2025 07:00:00 GMT

BioXcel Therapeutics, Inc
(NASDAQ:BTAI) 

BTAI stock logo

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic re...

Founded: 2017
Full Time Employees: 40
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends